Ignite Creation Date:
2024-05-06 @ 10:53 AM
Last Modification Date:
2024-10-26 @ 12:37 PM
Study NCT ID:
NCT03379727
Status:
COMPLETED
Last Update Posted:
2024-02-29
First Post:
2017-12-14
Brief Title:
Study to Assess the Safety and Efficacy of Midostaurin PKC412 in Combination With Standard Chemotherapy During Induction and Consolidation Followed by 12 Months of Maintenance Monotherapy in Patients With Newly-diagnosed FMS-like Tyrosine 3 FLT3 Kinase Receptor-mutated Acute Myeloid Leukemia
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-02-13
Start Date Type:
ACTUAL
Primary Completion Date:
2021-07-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-07-09
Completion Date Type:
ACTUAL
First Submit Date:
2017-12-14
First Submit QC Date:
December 19 2017
Study First Post Date:
2017-12-20
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2024-02-08
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-02-27
Last Update Post Date:
2024-02-29
Last Update Post Date Type:
ACTUAL